GSC
TRIB

Ground Swell Capital’s Trinity Biotech TRIB Stock Holding History

Ground Swell Capital’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,196
Closed -$24K – 111
2021
Q3 		$24K Buy
+2,196
New +$25.8K 0.1% 58
2014
Q3 		$16K Buy
174
+8
+5% +$866 0.03% 672
2014
Q2 		$19K Buy
+166
New +$19.7K 0.04% 430

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return

Ground Swell Capital's TRIB Position: Q4 2021 in Review

Ground Swell Capital sold out of Trinity Biotech (TRIB) in Q4 2021, closing a stake of 2,196 shares — an estimated $24K sold.

Ground Swell Capital first reported a position in TRIB in Q2 2014 and held it in 3 quarters. The position peaked at $24K in Q3 2021. 21 funds tracked by Wall St. Rank hold TRIB as of Q4 2021.

  • Ground Swell Capital reported no remaining Trinity Biotech position as of Q4 2021 after selling out during the quarter.
  • Ground Swell Capital sold 2,196 Trinity Biotech shares in Q4 2021, an estimated $24K.
  • Ground Swell Capital first reported a position in Trinity Biotech in Q2 2014 and held it in 3 quarters.
  • Ground Swell Capital's Trinity Biotech position peaked at $24K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2021.

Based on Ground Swell Capital's 13F filing for Q4 2021, filed 9 Feb 2022.